- Obamacare ruling ends threat to U.S. hospitals, insurers (reuters.com)
..hospital and health insurance industries…sigh of relief…Supreme Court upheld subsidies for individuals under…healthcare law. Shares in hospitals surged, with several hitting all-time highs,...analysts called the ruling positive for an industry on the edge of consolidation…economists have estimated $15 billion to $22 billion in healthcare spending was at risk...
- ScinoPharma to make API for Chinese drugmaker eyeing US celecoxib market (in-pharmatechnologist.com)
Raffles PharmaTech has contracted ScinoPharm to make the active pharmaceutical ingredient for a generic version...celecoxib being developed for the US market..will see the Taiwan-based API maker supply Raffles with the active pharmaceutical ingredient from its plant in Changshu, China...
- Pharm-Olam sets up in Paris citing French R&D tax credit as driver (outsourcing-pharma.com)EU Horizon 2020 (eur-lex.europa.eu)Research tax credit - France (france.fr)
Pharm-Olam has opened a Paris office citing changes to the rules governing drug research and development and French tax credits as the driver… "improvements in the regulatory process coupled with the EU Horizon 2020 initiative…"… had positioned France as a European leader in clinical research.
- The Surprising Future of Independent Pharmacy (pharmacytimes.com)
…22 years of experience in working with independent pharmacists, Lester Nathan, The Pharmacy Sage, discusses the future of independent pharmacy and offers insights on ways to make money as an independent pharmacist.
- Who is the Student Pharmacist? Check Out the Infographic (aacp.org)
Using data from American Association of Pharmacy Colleges surveys, the Office of Institutional Research and Effectiveness has put together a Student Pharmacist Q&A flyer (demographic profile overview)
- ‘Record-breaking’ 2015 will see surge in pharma acquisitions (in-pharmatechnologist.com)
Demand for central nervous system assets will help break records for pharma mergers and acquisitions in 2015,...Last year’s upsurge in financing to private pharma and firms with market capitalisation under $1bn has maintained momentum throughout Q1 2015...Meanwhile, partnering deals and mergers and acquisitions with large cap pharma companies continue to decrease since the last mega-merger peak in 2009.
- Pennsylvania Governor signs immunization bill (drugstorenews.com)
Gov. Tom Wolf signed into law on Friday House Bill 182, which allows pharmacists to administer the flu vaccine to patients 9 years of age and older,…bill also allows licensed, trained pharmacy interns to immunize under direct supervision of a pharmacist who possesses an immunization license…
- Pharmacy schools take a global route to solving world problems (pharmaceutical-journal.com)Three of World's Premier Pharmacy Schools form Landmark Alliance (pharmacy.unc.edu)
University of North Carolina in the United States, Monash University in Australia and University College London in England are joining forces to transform education and curriculum development, to pursue new and transformative research initiatives, and to enhance professional practice in pharmacy and the pharmaceutical sciences.
- Rising demand drives SGS to up capacity of Chinese testing labs (outsourcing-pharma.com)
SGS Life Science Services has completed construction of its Shanghai …, cGMP chemistry and biotechnology testing laboratories and will further increase space at its microbiology lab at the site. The facility also currently provides services for method development and validation, testing of raw materials, APIs and finished products, as well as testing of traditional Chinese medicines.
- National “Right To Try” Website Launches; Patients Asked to Share Their Stories (businesswire.com)Right To Try website (righttotry.org)Sandoval signs ‘Right to Try’ bill for the terminally ill (reviewjournal.com)
Goldwater Institute launched RightToTry.org, the official website of the national movement to adopt Right To Try laws in all 50 states….allow doctors to prescribe treatments to the terminally ill that are being used in clinical trials but are not yet on pharmacy shelves…expands access to potentially life-saving treatments…

